Skip to main content
Fig. 3 | Orphanet Journal of Rare Diseases

Fig. 3

From: Prevalence of morbidities across the lifespan for adults with spinal muscular atrophy: a retrospective cohort study

Fig. 3

Prevalence of morbidities by age group part 2. Crude prevalence with 95% confidence intervals (vertical lines) for morbidities of the musculoskeletal and neurological systems, as well as mental health, substance abuse, and sleep disorders for adults (females and male combined) with (solid line) and without (dotted line) spinal muscular atrophy. Estimates are not reported if the number of outcome cases was less than 11 for patient de-identification purposes. For each prevalence estimate, the difference is statistically significant at P ≤ 0.05 if the 95% confidence interval does not overlap between cohorts

Back to article page